Feyzi Sinan Tokalı - Concepedia

Concepedia

Author

Feyzi Sinan Tokalı

Kafkas University ORCID

Also Known As

Feyzi S. Tokalı, Feyzi Sinan TOKALI, Feyzi Sinan Tokali, Feyzi Sinan Tokalı, Furkan Çakır, Pelin Tokalı

54

Publications

1.2K

Citations

23

H-Index

36

Concepts

All Affiliations

Kafkas University Bezmiâlem Vakıf Üniversitesi Atatürk University Ardahan University Eskişehir City Hospital

FS

About

Feyzi Sinan Tokalı is an author at Kafkas University specializing in pharmacology, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	10	10	446
2	Natural Sciences	9	9	422
3	Medicine	8	8	329
4	Engineering	2	2	49
5	Biomolecular Engineering	1	1	23

Feyzi Sinan Tokalı

×

35

Publications

1.2K

Citations

23

H-Index

	Year	Citations
Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors Yeliz Demir, Feyzi Sinan Tokalı, Erbay Kalay, Molecular Diversity Medicinal ChemistryAldo-keto ReductaseBiochemistryMedicineNatural Sciences	2022	85
Synthesis, characterization, biological activity and molecular docking studies of novel schiff bases derived from thiosemicarbazide: Biochemical and computational approach Feyzi Sinan Tokalı, Hande Usanmaz, Muhammet Karaman, Journal of Molecular Structure Biological ActivityCombinatorial ChemistryMedicinal ChemistryPharmaceutical ChemistryBiochemistry	2020	70
Novel acetic acid derivatives containing quinazolin‐4(3<i>H</i>)‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors Feyzi Sinan Tokalı, Yeliz Demir, Cüneyt Türkeş, Drug Development Research	2023	67
Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin‐4(<scp>3<i>H</i></scp>)‐one derivatives as potential aldose reductase inhibitors Feyzi Sinan Tokalı, Yeliz Demir, İbrahim Hakkı Demircioğlu, Drug Development Research	2021	57
Synthesis and Evaluation of Quinazolin‐4(3 <i>H</i> )‐one Derivatives as Multitarget Metabolic Enzyme Inhibitors: A Biochemistry‐Oriented Drug Design Feyzi Sinan Tokalı, Morteza Sadeghi, Halil Şenol ChemistrySelect	2023	51
Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies Feyzi Sinan Tokalı, Halil Şenol, Hande İpek Yetke, Archiv der Pharmazie	2023	50
Design, synthesis, molecular docking, and some metabolic enzyme inhibition properties of novel quinazolinone derivatives Feyzi Sinan Tokalı, İbrahim Hakkı Demircioğlu, Muhammet Karaman, Archiv der Pharmazie	2021	44
Synthesis, characterization and molecular docking studies of highly selective new hydrazone derivatives of anthranilic acid and their ring closure analogue Quinazolin-4(3H)-ones against lung cancer cells A549 Feyzi Sinan Tokalı, Halil Şenol, Şeyma Bulut, Journal of Molecular Structure Medicinal ChemistryDerivative (Chemistry)Natural SciencesMedicineChemistry	2023	43
Synthesis of new carboxylates and sulfonates containing thiazolidin-4-one ring and evaluation of inhibitory properties against some metabolic enzymes Feyzi Sinan Tokalı, Burak Tüzün, Ahmet KARAKUŞ, Journal of the Iranian Chemical Society BiosynthesisBiochemistryThiazolidin-4-one RingMetabolic EnzymesPharmacology	2023	42
Novel Quinazolinone Derivatives: Potential Synthetic Analogs for the Treatment of Glaucoma, Alzheimer's Disease and Diabetes Mellitus Feyzi Sinan Tokalı, Burak Tüzün, Ahmet KARAKUŞ, Chemistry & Biodiversity	2023	42

Page 1